La mediación en las organizaciones, contribuciones para una cultura de paz

Organizations are integrated by different people, who interact with the purpose of achieving the objectives proposed by the institution. From this interaction, controversies and disagreements that could generate internal discomfort (shareholders, collaborators, managers, etc.), and external discomfort (suppliers, customers, society in general) arise. Hence, organizations are called to intervene and promote a healthy environment for their members, applying many instruments and mechanisms, in order to solve conflicts peacefully; for which mediation is considered an effective tool that seeks a culture of organizational peace; and social responsibility of entities, both, with their employee and the community, strengthening a coexistence of respect, solidarity and equity.Las organizaciones están compuestas por diferentes personas, que interactúan con la finalidad de lograr los objetivos propuestos por la institución. De esa interacción se presentan controversias y desacuerdos que podrían generar malestar a lo interno (accionistas, colaborares, directivos, etc.), y, a lo externo (proveedores, clientes, sociedad en general). De ahí que, las organizaciones están llamadas a intervenir y promover un ambiente saludable a sus integrantes, aplicando diversos instrumentos y mecanismos, a fin de solucionar de forma pacífica los conflictos; para lo cual, se considera a la mediación como una herramienta efectiva que procura una Cultura de Paz organizacional; y, responsabilidad social de las entidades, tanto con sus colaboradores y frente a la comunidad, afianzando una convivencia de respeto, solidaridad y equidad

Link

Conversation between the editors of this edition, Gabriela Ponce and Marcela Correa, the general editor of post(s), Anamaría Garzón, and Genoveva Mora, director of El Apuntador. Link is a reflection on the themes discussed in this issue of the magazine. Conversación entre las editoras de esta edición, Gabriela Ponce y Marcela Correa, la editora general de post(s), Anamaría Garzón, y Genoveva Mora, directora de El Apuntador. Link es una reflexión sobre el tema tratado en esta edición de la revista.&nbsp

Marine invertebrate and seaweed biodiversity of continental coastal Ecuador

This study summarises the diversity of living macroinvertebrates and seaweeds from the intertidal and subtidal rocky shores along Ecuadorian continental coast. Benthic macroinvertebrate communities and seaweeds were quantified over quadrants (50 × 50 cm) randomly placed on transects of 50 m length. A checklist of 612 species was generated: 479 species of macroinvertebrates and 133 species of seaweeds. Groups recorded were Mollusca (184 species), Cnidaria (70), Arthropoda (68), Annelida (60), Echinodermata (42), Chordata (18), Bryozoa (13), Porifera (22), Sipuncula (2), Brachiopoda and Platyhelminthes (only identified as morphotypes). The seaweeds were represented by Rhodophyta (78), Chlorophyta (37), Ochrophyta (13), Cyanobacteria (5) and 19 biotic complexes. Furthermore, 22 new taxa and six alien species were recorded from the intertidal zone. This study provides the first large scale report of benthic communities in different marine coastal ecosystems in mainland Ecuador, covering 1,478 km2 of protected areas and 382 km2 of non-protected areas. The highest benthic diversity was registered in the protected areas and rocky shores from the intertidal zone. The biological data, herein reported, are useful for a long-term monitoring programme to evaluate the status of conservation and to detect rapid changes in the benthic biodiversity from coastal areas.Fil: Cárdenas Calle, Maritza. División Ambiental. Bioelite, Guayaquil; Ecuador. Universidad de Guayaquil. Ciudadela Universitaria; EcuadorFil: Mora, Elba. División Ambiental. Bioelite, Guayaquil; EcuadorFil: Torres, Genoveva. Universidad de Guayaquil. Ciudadela Universitaria; EcuadorFil: Pérez Correa, Julián. Universidad Espíritu Santo; EcuadorFil: Bigatti, Gregorio. Consejo Nacional de Investigaciones Científicas y Técnicas. Centro Científico Tecnológico Conicet - Centro Nacional Patagónico. Instituto de Biología de Organismos Marinos; ArgentinaFil: Signorelli, Javier Hernan. Consejo Nacional de Investigaciones Científicas y Técnicas. Centro Científico Tecnológico Conicet - Centro Nacional Patagónico. Instituto de Biología de Organismos Marinos; ArgentinaFil: Coronel, Jorge. Universidad Agraria del Ecuador; Ecuado

Boletín Mensual Momento Económico (nueva época) Número 7 Marzo 2011

Temas diversos y de diferentes expresiones económicas ocupan este núme-ro de Momento Económico. Ha sido, y así continuará, una preocupación del GACEM la reflexión sobre la economía mundial, no sólo porque nos resulta evidente su articulación global, sino porque la economía mexicana es parte de ese engranaje a partir de las relaciones comercial, financiera y de trabajadores que mantiene con la economía estadounidense. En los últi-mos meses ha ocupado la atención de sirios y troyanos, el tema del monto y contenido del déficit público de diversos países europeos y, especialmen-te, el de Estados Unidos. De ahí la colaboración de Eugenia Correa, profe-sora del posgrado de la Facultad de Economía y experta en el tema, con el artículo “Déficit público y mercados financieros en crisis”, en el cual se in-siste que no es posible encontrar una relación unívoca entre déficit público e inflación y que por el contrario sí es posible encontrar la relación entre déficit y crecimiento económico. Otro tema de particular importancia para la economía mexicana es el referente al sector turismo, Gustavo López Pardo, investigador de este instituto y Armando Mújica Romo, académico de la Facultad de Econom-ía, colaboraron con la nota “¿Acuerdo Nacional por el Turismo: visión o espejismo?”, en la que se investiga el contenido y proyección del Acuerdo Nacional para el Turismo y, a partir de información cuantitativa y cualita-tiva, cuestionan la posibilidad de que dicha actividad se convierta en motor de crecimiento y desarrollo del país. Por último, Alejandro López Bolaños, colaborador del GACEM, presenta en un recuadro otro tema de gran importancia, “Los salarios en México y en los países de la OCDE” en el que se corrobora que los salarios son los más bajos entre los países miembros de dicha organización y aun comparados con otros países latinoamericanos y europeos, se localizan en las escalas inferiores. Contenido: Presentación. p1 Déficit público y mercados financieros en crisis. p2 ¿Acuerdo Nacional por el Turismo: Visión o espejismo? p6 Los salarios en México y en los países de la OCDE. p1

A Multicenter, International Collaborative Study for American Joint Committee on Cancer Staging of Retinoblastoma Part I : Metastasis-Associated Mortality

Purpose: To evaluate the ability of the 8th edition of the American Joint Committee on Cancer (AJCC) Cancer Staging Manual to estimate metastatic and mortality rates for children with retinoblastoma (RB). Design: International, multicenter, registry-based retrospective case series. Participants: A total of 2190 patients from 18 ophthalmic oncology centers from 13 countries over 6 continents. Methods: Patient-specific data fields for RB were designed and selected by subcommittee. All patients with RB with adequate records to allow tumor staging by the AJCC criteria and follow-up for metastatic disease were studied. Main Outcome Measures: Metastasis-related 5- and 10-year survival data after initial tumor staging were estimated with the KaplaneMeier method depending on AJCC clinical (cTNM) and pathological (pTNM) tumor, node, metastasis category and age, tumor laterality, and presence of heritable trait. Results: Of 2190 patients, the records of 2085 patients (95.2%) with 2905 eyes were complete. The median age at diagnosis was 17.0 months. A total of 1260 patients (65.4%) had unilateral RB. Among the 2085 patients, tumor categories were cT1a in 55 (2.6%), cT1b in 168 (8.1%), cT2a in 197 (9.4%), cT2b in 812 (38.9%), cT3 in 835 (40.0%), and cT4 in 18 (0.9%). Of these, 1397 eyes in 1353 patients (48.1%) were treated with enucleation. A total of 109 patients (5.2%) developed metastases and died. The median time (n = 92) from diagnosis to metastasis was 9.50 months. The 5-year KaplaneMeier cumulative survival estimates by clinical tumor categories were 100% for category cT1a, 98% (95% confidence interval [CI], 97-99) for cT1b and cT2a, 96% (95% CI, 95-97) for cT2b, 89% (95% CI, 88-90) for cT3 tumors, and 45% (95% CI, 31-59) for cT4 tumors. Risk of metastasis increased with increasing cT (and pT) category (P <0.001). Cox proportional hazards regression analysis confirmed a higher risk of metastasis in category cT3 (hazard rate [HR], 8.09; 95% CI, 2.55-25.70; P <0.001) and cT4 (HR, 48.55; 95% CI, 12.86-183.27; P <0.001) compared with category cT1. Age, tumor laterality, and presence of heritable traits did not influence the incidence of metastatic disease. Conclusions: Multicenter, international, internet-based data sharing facilitated analysis of the 8th edition AJCC RB Staging System for metastasis-related mortality and offered a proof of concept yielding quantitative, predictive estimates per category in a large, real-life, heterogeneous patient population with RB. (C) 2020 by the American Academy of Ophthalmology. This is an open access article under the CC BY-NC-ND licensePeer reviewe

Prevalence of, and risk factors for, dental sequelae in adolescents who underwent cancer therapy during childhood

Introduction: The increase in survival rates in children treated for cancer has been accompanied by a rise in sequelae in permanent teeth. The aim of the study was to correlate the type of cancer therapy administered to patients during early childhood and the dental sequelae recorded in survivors. Material and methods: Single-center retrospective cohort study carried out at the Children's University Hospital of Sant Joan de Déu in Barcelona, Spain. Hundred and nine patients who had received cancer treatment during early childhood were randomly examined and grouped according to diagnosis and cancer therapy received. The type of therapy was correlated with the number and severity of dental lesions that patients presented in adolescence. Results: Dental sequelae of some kind were present in 85.3% of patients. Microdontia was the most prevalent (52.3%). Treatment with alkylating agents had a relative risk of presenting moderate lesions of 3.36 (1.18-9.60), and one of 2.29 (1.07-4.91) of presenting severe lesions. Topoisomerase inhibitors and cytotoxic antibiotics presented relative risks of 1.6 (1.07-2.38) and 2.08 (1.02-4.26) of root alterations and agenesis, respectively. Conclusions: Treatment with alkylating agents together with cytotoxic antibiotics and topoisomerase inhibitors was associated with a higher relative risk of microdontia, agenesis, and root shortening

Reflexiones en torno al impacto de las tecnologías emergentes en la educación: Caso Latinoamérica

Las tecnologías emergentes han transformado la educación superior a través de la integración de herramientas y sistemas como la Inteligencia Artificial en los programas académicos globales, estas innovaciones no solo han propiciado la mutación de la enseñanza, sino el modo en que interactúan estudiantes y docentes, redefiniendo las metodologías pedagógicas tradicionales. Este escenario educativo plantea nuevos desafíos y oportunidades en términos de democratización del acceso al conocimiento, la personalización del aprendizaje y la colaboración a nivel global. A la par, supone obstáculos como la brecha digital, la capacitación del personal docente y la protección de la privacidad online. A pesar de estos desafíos, las herramientas web se han encargado de promover una mayor participación y colaboración entre todos los actores intervinientes, expandiendo el acceso al conocimiento y facilitando la gestión institucional. En estas condiciones, las tecnologías emergentes -como se verá- se tornan fundamentales para el futuro de la educación superior, aunque las mismas precisan abordar, con cuidado, las brechas y desafíos asociados con miras a fortalecerse en el panorama educativo latinoamericano y global

Recurrent somatic chromosomal abnormalities in relapsed extraocular retinoblastoma

Most reports about copy number alterations (CNA) in retinoblastoma relate to patients with intraocular disease and features of children with extraocular relapse remain unknown, so we aimed to describe the CNA in this population. We evaluated 23 patients and 27 specimens from 4 centers. Seventeen cases had extraocular relapse after initial enucleation and six cases after an initial preservation attempt. We performed an analysis of CNA and BCOR gene alteration by SNP array (Single Nucleotide Polymorfism array), whole-exome sequencing, IMPACT panel and CGH array (Array-based comparative genomic hybridization). All cases presented CNA at a higher prevalence than those reported in previously published studies for intraocular cases. CNA previously reported for intraocular retinoblastoma were found at a high frequency in our cohort: gains in 1q (69.5%), 2p (60.9%) and 6p (86.9%), and 16q loss (78.2%). Other, previously less-recognized, CNA were found including loss of 11q (34.8%), gain of 17q (56.5%), loss of 19q (30.4%) and BCOR alterations were present in 72.7% of our cases. A high number of CNA including 11q deletions, 17q gains, 19q loss, and BCOR alterations, are more common in extraocular retinoblastoma. Identification of these features may be correlated with a more aggressive tumor warranting consideration for patient management.Fil: Aschero, María del Rosario. Gobierno de la Ciudad de Buenos Aires. Hospital de Pediatría "Juan P. Garrahan"; Argentina. Consejo Nacional de Investigaciones Científicas y Técnicas; ArgentinaFil: Francis, Jasmine H.. Memorial Sloan-Kettering Cancer Center; Estados UnidosFil: Ganiewich, Daiana. Consejo Nacional de Investigaciones Científicas y Técnicas. Oficina de Coordinación Administrativa Parque Centenario. Instituto de Investigaciones Bioquímicas de Buenos Aires. Fundación Instituto Leloir. Instituto de Investigaciones Bioquímicas de Buenos Aires; ArgentinaFil: Gomez Gonzalez, Soledad. Hospital Sant Joan de Deu Barcelona; EspañaFil: Sampor, Claudia. Gobierno de la Ciudad de Buenos Aires. Hospital de Pediatría "Juan P. Garrahan"; ArgentinaFil: Zugbi, Santiago. Gobierno de la Ciudad de Buenos Aires. Hospital de Pediatría "Juan P. Garrahan"; Argentina. Consejo Nacional de Investigaciones Científicas y Técnicas; ArgentinaFil: Ottaviani, Daniela. Universite de Paris; Francia. Institute Curie; Francia. Centre National de la Recherche Scientifique; FranciaFil: Lemelle, Lauriane. Universite de Paris; Francia. Institute Curie; Francia. Centre National de la Recherche Scientifique; FranciaFil: Mena, Marcela Daniela C. Gobierno de la Ciudad de Buenos Aires. Hospital de Pediatría "Juan P. Garrahan"; ArgentinaFil: Winter, Ursula Andrea. Gobierno de la Ciudad de Buenos Aires. Hospital de Pediatría "Juan P. Garrahan"; Argentina. Consejo Nacional de Investigaciones Científicas y Técnicas; ArgentinaFil: Correa Llano, Genoveva. Hospital Sant Joan de Deu Barcelona; EspañaFil: Lamas, Gabriela. Gobierno de la Ciudad de Buenos Aires. Hospital de Pediatría "Juan P. Garrahan"; ArgentinaFil: Lubieniecki, Fabiana. Gobierno de la Ciudad de Buenos Aires. Hospital de Pediatría "Juan P. Garrahan"; ArgentinaFil: Szijan, Irene. Universidad de Buenos Aires. Facultad de Farmacia y Bioquímica. Departamento de Microbiología, Inmunología y Biotecnología. Cátedra de Genética y Biología Molecular; ArgentinaFil: Mora, Jaume. Hospital Sant Joan de Deu Barcelona; EspañaFil: Podhajcer, Osvaldo Luis. Consejo Nacional de Investigaciones Científicas y Técnicas. Oficina de Coordinación Administrativa Parque Centenario. Instituto de Investigaciones Bioquímicas de Buenos Aires. Fundación Instituto Leloir. Instituto de Investigaciones Bioquímicas de Buenos Aires; ArgentinaFil: Doz, François. Universite de Paris; Francia. Institute Curie; Francia. Centre National de la Recherche Scientifique; FranciaFil: Radvanyi, François. Universite de Paris; Francia. Institute Curie; Francia. Centre National de la Recherche Scientifique; FranciaFil: Abramson, David H.. Memorial Sloan-Kettering Cancer Center; Estados UnidosFil: Llera, Andrea Sabina. Consejo Nacional de Investigaciones Científicas y Técnicas. Oficina de Coordinación Administrativa Parque Centenario. Instituto de Investigaciones Bioquímicas de Buenos Aires. Fundación Instituto Leloir. Instituto de Investigaciones Bioquímicas de Buenos Aires; ArgentinaFil: Schaiquevich, Paula Susana. Gobierno de la Ciudad de Buenos Aires. Hospital de Pediatría "Juan P. Garrahan"; Argentina. Consejo Nacional de Investigaciones Científicas y Técnicas; ArgentinaFil: Lavarino, Cinzia. Hospital Sant Joan de Deu Barcelona; EspañaFil: Chantada, Guillermo Luis. Gobierno de la Ciudad de Buenos Aires. Hospital de Pediatría "Juan P. Garrahan"; Argentina. Hospital Sant Joan de Deu Barcelona; España. Consejo Nacional de Investigaciones Científicas y Técnicas; Argentin

Antimicrobial resistance among migrants in Europe: a systematic review and meta-analysis

BACKGROUND: Rates of antimicrobial resistance (AMR) are rising globally and there is concern that increased migration is contributing to the burden of antibiotic resistance in Europe. However, the effect of migration on the burden of AMR in Europe has not yet been comprehensively examined. Therefore, we did a systematic review and meta-analysis to identify and synthesise data for AMR carriage or infection in migrants to Europe to examine differences in patterns of AMR across migrant groups and in different settings. METHODS: For this systematic review and meta-analysis, we searched MEDLINE, Embase, PubMed, and Scopus with no language restrictions from Jan 1, 2000, to Jan 18, 2017, for primary data from observational studies reporting antibacterial resistance in common bacterial pathogens among migrants to 21 European Union-15 and European Economic Area countries. To be eligible for inclusion, studies had to report data on carriage or infection with laboratory-confirmed antibiotic-resistant organisms in migrant populations. We extracted data from eligible studies and assessed quality using piloted, standardised forms. We did not examine drug resistance in tuberculosis and excluded articles solely reporting on this parameter. We also excluded articles in which migrant status was determined by ethnicity, country of birth of participants' parents, or was not defined, and articles in which data were not disaggregated by migrant status. Outcomes were carriage of or infection with antibiotic-resistant organisms. We used random-effects models to calculate the pooled prevalence of each outcome. The study protocol is registered with PROSPERO, number CRD42016043681. FINDINGS: We identified 2274 articles, of which 23 observational studies reporting on antibiotic resistance in 2319 migrants were included. The pooled prevalence of any AMR carriage or AMR infection in migrants was 25·4% (95% CI 19·1-31·8; I2 =98%), including meticillin-resistant Staphylococcus aureus (7·8%, 4·8-10·7; I2 =92%) and antibiotic-resistant Gram-negative bacteria (27·2%, 17·6-36·8; I2 =94%). The pooled prevalence of any AMR carriage or infection was higher in refugees and asylum seekers (33·0%, 18·3-47·6; I2 =98%) than in other migrant groups (6·6%, 1·8-11·3; I2 =92%). The pooled prevalence of antibiotic-resistant organisms was slightly higher in high-migrant community settings (33·1%, 11·1-55·1; I2 =96%) than in migrants in hospitals (24·3%, 16·1-32·6; I2 =98%). We did not find evidence of high rates of transmission of AMR from migrant to host populations. INTERPRETATION: Migrants are exposed to conditions favouring the emergence of drug resistance during transit and in host countries in Europe. Increased antibiotic resistance among refugees and asylum seekers and in high-migrant community settings (such as refugee camps and detention facilities) highlights the need for improved living conditions, access to health care, and initiatives to facilitate detection of and appropriate high-quality treatment for antibiotic-resistant infections during transit and in host countries. Protocols for the prevention and control of infection and for antibiotic surveillance need to be integrated in all aspects of health care, which should be accessible for all migrant groups, and should target determinants of AMR before, during, and after migration. FUNDING: UK National Institute for Health Research Imperial Biomedical Research Centre, Imperial College Healthcare Charity, the Wellcome Trust, and UK National Institute for Health Research Health Protection Research Unit in Healthcare-associated Infections and Antimictobial Resistance at Imperial College London

Surgical site infection after gastrointestinal surgery in high-income, middle-income, and low-income countries: a prospective, international, multicentre cohort study

Background: Surgical site infection (SSI) is one of the most common infections associated with health care, but its importance as a global health priority is not fully understood. We quantified the burden of SSI after gastrointestinal surgery in countries in all parts of the world. Methods: This international, prospective, multicentre cohort study included consecutive patients undergoing elective or emergency gastrointestinal resection within 2-week time periods at any health-care facility in any country. Countries with participating centres were stratified into high-income, middle-income, and low-income groups according to the UN's Human Development Index (HDI). Data variables from the GlobalSurg 1 study and other studies that have been found to affect the likelihood of SSI were entered into risk adjustment models. The primary outcome measure was the 30-day SSI incidence (defined by US Centers for Disease Control and Prevention criteria for superficial and deep incisional SSI). Relationships with explanatory variables were examined using Bayesian multilevel logistic regression models. This trial is registered with ClinicalTrials.gov, number NCT02662231. Findings: Between Jan 4, 2016, and July 31, 2016, 13 265 records were submitted for analysis. 12 539 patients from 343 hospitals in 66 countries were included. 7339 (58·5%) patient were from high-HDI countries (193 hospitals in 30 countries), 3918 (31·2%) patients were from middle-HDI countries (82 hospitals in 18 countries), and 1282 (10·2%) patients were from low-HDI countries (68 hospitals in 18 countries). In total, 1538 (12·3%) patients had SSI within 30 days of surgery. The incidence of SSI varied between countries with high (691 [9·4%] of 7339 patients), middle (549 [14·0%] of 3918 patients), and low (298 [23·2%] of 1282) HDI (p < 0·001). The highest SSI incidence in each HDI group was after dirty surgery (102 [17·8%] of 574 patients in high-HDI countries; 74 [31·4%] of 236 patients in middle-HDI countries; 72 [39·8%] of 181 patients in low-HDI countries). Following risk factor adjustment, patients in low-HDI countries were at greatest risk of SSI (adjusted odds ratio 1·60, 95% credible interval 1·05–2·37; p=0·030). 132 (21·6%) of 610 patients with an SSI and a microbiology culture result had an infection that was resistant to the prophylactic antibiotic used. Resistant infections were detected in 49 (16·6%) of 295 patients in high-HDI countries, in 37 (19·8%) of 187 patients in middle-HDI countries, and in 46 (35·9%) of 128 patients in low-HDI countries (p < 0·001). Interpretation: Countries with a low HDI carry a disproportionately greater burden of SSI than countries with a middle or high HDI and might have higher rates of antibiotic resistance. In view of WHO recommendations on SSI prevention that highlight the absence of high-quality interventional research, urgent, pragmatic, randomised trials based in LMICs are needed to assess measures aiming to reduce this preventable complication